FDA: Pelvic Mesh Used To Treat Prolapse Can Erode Vagina In 11-18 Percent Of Cases

(February 12, 2019, 1:39 PM EST) -- SILVER SPRING, Md. — The use of surgical mesh to treat pelvic organ prolapse (POP) is less favorable than the use of “native tissue,” the Food and Drug Administration staff says in a summary prepared for a Feb. 12 advisory committee meeting on the topic....

Related Sections